Intraarterial Hepatic SPECT/CT Imaging Using 99mTc-Macroaggregated Albumin in Preparation for Radioembolization
- PMID: 26089551
- DOI: 10.2967/jnumed.114.153346
Intraarterial Hepatic SPECT/CT Imaging Using 99mTc-Macroaggregated Albumin in Preparation for Radioembolization
Abstract
Current standard practice for radioembolization treatment planning makes use of nuclear medicine imaging (NMI) of (99m)Tc-macroaggregated albumin ((99m)Tc-MAA) arterial distributions for the assessment of lung shunting and extrahepatic uptake. Our aim was to retrospectively compare NMI with mapping angiography in the detection and localization of extrahepatic (99m)Tc-MAA and to evaluate the typical and atypical findings of NMI in association with catheter placement.
Methods: One hundred seventy-four patients underwent diagnostic angiography in preparation for radioembolization. (99m)Tc-MAA was administered to the liver via a microcatheter positioned in the desired hepatic artery. Planar scintigraphy imaging followed by SPECT/CT imaging was obtained within 2 h. All images were reviewed for hepatic and extrahepatic (99m)Tc-MAA deposition and compared with the mapping angiogram.
Results: Intrahepatic lobe shunting was present on NMI in only 2.9% of the cases but was present in 62.5% of the patients with portal vein thrombosis. Extrahepatic distributions included lungs (100%), the gallbladder (49%) if present, and locations involving hepaticoenteric arterial anatomy recognized on angiograms (16%). Free pertechnetate was identified on 38% of the nuclear medicine images. Three percent of nuclear medicine images showed alternative findings such as a thyroid nodule or metallic artifact.
Conclusion: Patients being considered for radioembolization should undergo both angiography and scintigraphy for the assessment of hepaticoenteric arterial anatomy, hepatopulmonary shunting, and appropriate dosimetry considerations. Knowledge of the expected distribution of (99m)Tc-MAA with normal variants and potential nontarget delivery to adjacent structures is critical in improving clinical outcomes.
Keywords: 90Y-microspheres; 99mTc-macroaggregated albumin; SPECT/CT; liver neoplasms; radioembolization; radiotherapy.
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Similar articles
-
SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.J Nucl Med. 2009 May;50(5):688-92. doi: 10.2967/jnumed.108.058347. Epub 2009 Apr 16. J Nucl Med. 2009. PMID: 19372479 Clinical Trial.
-
Computed tomography hepatic arteriography has a hepatic falciform artery detection rate that is much higher than that of digital subtraction angiography and 99mTc-MAA SPECT/CT: implications for planning 90Y radioembolization?Eur J Radiol. 2012 Dec;81(12):3979-84. doi: 10.1016/j.ejrad.2012.08.007. Epub 2012 Sep 3. Eur J Radiol. 2012. PMID: 22954411 Clinical Trial.
-
The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment.J Nucl Med. 2010 Aug;51(8):1206-12. doi: 10.2967/jnumed.109.074559. Epub 2010 Jul 21. J Nucl Med. 2010. PMID: 20660379
-
Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):559-75. doi: 10.1007/s00259-015-3157-8. Epub 2015 Sep 4. Eur J Nucl Med Mol Imaging. 2016. PMID: 26338177 Free PMC article. Review.
-
(90)Y Radioembolization: Multimodality Imaging Pattern Approach with Angiographic Correlation for Optimized Target Therapy Delivery.Radiographics. 2015 Sep-Oct;35(5):1602-18. doi: 10.1148/rg.2015140314. Epub 2015 Jul 31. Radiographics. 2015. PMID: 26230755 Review.
Cited by
-
Maximum tumor-absorbed dose measured by voxel-based multicompartmental dosimetry as a response predictor in yttrium-90 radiation segmentectomy for hepatocellular carcinoma.EJNMMI Phys. 2023 Feb 6;10(1):7. doi: 10.1186/s40658-022-00520-9. EJNMMI Phys. 2023. PMID: 36745227 Free PMC article.
-
Radiochemical Feasibility of Mixing of 99mTc-MAA and 90Y-Microspheres with Omnipaque Contrast.Molecules. 2022 Nov 7;27(21):7646. doi: 10.3390/molecules27217646. Molecules. 2022. PMID: 36364476 Free PMC article.
-
The increasing potential of nuclear medicine imaging for the evaluation and reduction of normal tissue toxicity from radiation treatments.Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3762-3775. doi: 10.1007/s00259-021-05284-5. Epub 2021 Mar 9. Eur J Nucl Med Mol Imaging. 2021. PMID: 33687522 Free PMC article. Review.
-
Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group.Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1695-1704. doi: 10.1007/s00259-019-04340-5. Epub 2019 May 16. Eur J Nucl Med Mol Imaging. 2019. PMID: 31098749
-
Evaluation of Blood Parameters Alteration Following Low-dose Radiation Induced by Myocardial Perfusion Imaging.J Biomed Phys Eng. 2018 Jun 1;8(2):179-184. eCollection 2018 Jun. J Biomed Phys Eng. 2018. PMID: 29951444 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical